Log in to save to my catalogue

P07.01 The potential role of extracellular vesicle-derived small RNAS in AML research as non-invasiv...

P07.01 The potential role of extracellular vesicle-derived small RNAS in AML research as non-invasiv...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2724368781

P07.01 The potential role of extracellular vesicle-derived small RNAS in AML research as non-invasive biomarker

About this item

Full title

P07.01 The potential role of extracellular vesicle-derived small RNAS in AML research as non-invasive biomarker

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A24-A25

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundAntileukemic responses of immune reactive cells in AML-patients need to be improved. Combinations of blast-modulatory kitM (GM-CSF+PGE1) (vs control) convert myeloid blasts into dendritic cells of leukemic origin (DCleu), that effectively activate immune-cells against leukemic blasts. DC-derived EVs express molecules and carry nucleic aci...

Alternative Titles

Full title

P07.01 The potential role of extracellular vesicle-derived small RNAS in AML research as non-invasive biomarker

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2724368781

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2724368781

Other Identifiers

E-ISSN

2051-1426

DOI

10.1136/jitc-2022-ITOC9.45

How to access this item